EFFICACY OF CARBOPLATIN plus WEEKLY NAB-PACLITAXEL FOR ELDERLY ADVANCED/RECURRENT NON-SMALL CELL LUNG CANCER (E-NSCLC)

被引：0
|
作者：
Shibata, Kazuhiko [1 ,2 ]
Shibata, Yoshihiro [1 ]
Takase, Misae [2 ]
Takahashi, Miyuki [2 ,3 ]
机构：
[1] Koseiren Takaoka Hosp, Dept Med Oncol, Toyama, Japan
[2] Koseiren Takaoka Hosp, Comprehens Canc Ctr, Toyama, Japan
[3] Koseiren Takaoka Hosp, Dept Nursing, Toyama, Japan
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu436.35
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-17-4
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Safety and pharmacokinetic study of nab-paclitaxel plus carboplatin in chemotherapy-naive patients with advanced non-small cell lung cancer
    Okamoto, Isamu
    Yamamoto, Nobuyuki
    Kubota, Kaoru
    Ohe, Yuichiro
    Nogami, Naoyuki
    Murakami, Haruyasu
    Yamaya, Hidetoshi
    Ono, Katsuhiro
    Nakagawa, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (03) : 1132 - 1137
  • [32] First-line nab-paclitaxel plus carboplatin for patients with advanced non-small cell lung cancer: Results of the NEPTUN study
    Dechow, Tobias
    Riera-Knorrenschild, Jorge
    Hackanson, Bjoern
    Janssen, Jan
    Schulz, Holger
    Chiabudini, Marco
    Fischer von Weikersthal, Ludwig
    Budweiser, Stephan
    Nacke, Axel
    Taeuscher, Dagmar
    Welslau, Manfred
    Potthoff, Karin
    CANCER MEDICINE, 2021, 10 (22): : 8127 - 8137
  • [33] nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial
    Gridelli, Cesare
    Chen, Tianlei
    Ko, Amy
    O'Brien, Mary E.
    Ong, Teng Jin
    Socinski, Mark A.
    Postmus, Pieter E.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 1445 - 1451
  • [34] Carboplatin Plus Nab-paclitaxel in Performance Status 2 Patients With Advanced Non-small-cell Lung Cancer
    Nakashima, Kazuhisa
    Akamatsu, Hiroaki
    Murakami, Haruyasu
    Niwa, Takashi
    Iwamoto, Yasuo
    Ozawa, Yuichi
    Yokoyama, Toshihide
    Shoda, Hiroyasu
    Yamamoto, Nobuyuki
    Yoshioka, Hiroshige
    Masuda, Ken
    Naito, Tateaki
    Mori, Keita
    Takahashi, Toshiaki
    ANTICANCER RESEARCH, 2019, 39 (03) : 1463 - 1468
  • [35] nab-Paclitaxel plus Carboplatin for Elderly Patients with Advanced NSCLC (ABOUND.70+)
    Langer, Corey J.
    Amiri, Katayoun I.
    Coleman, Morton
    Haggstrom, Daniel
    Konduri, Katrik
    Sanford, Alexandra
    Skinner, William
    Smith, David
    Socoteanu, Matei
    Trunova, Nataliya
    Weiss, Jared
    Santos, Edgardo
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S551 - S551
  • [36] Carboplatin plus gemcitabine followed by weekly paclitaxel in advanced and metastatic non-small cell lung cancer (NSCLC): A phase II study
    Tjan-Heijnen, V
    Timmer-Bonte, J
    van der Drift, M
    van Leeuwen, F
    de Boo, T
    Wagenaar, M
    van Die, L
    Bussink, J
    LUNG CANCER, 2005, 49 : S272 - S272
  • [37] Safety and efficacy of sequential chemotherapy with carboplatin plus gemcitabine followed by weekly paclitaxel in advanced non-small cell lung cancer
    Patricia M. M. B. Soetekouw
    Johanna N. H. Timmer-Bonte
    Miep A. van der Drift
    Frank van Leeuwen
    Michiel Wagenaar
    Lya van Die
    Jan Bussink
    Vivianne C. G. Tjan-Heijnen
    International Journal of Clinical Oncology, 2013, 18 : 988 - 996
  • [38] Safety and efficacy of sequential chemotherapy with carboplatin plus gemcitabine followed by weekly paclitaxel in advanced non-small cell lung cancer
    Soetekouw, Patricia M. M. B.
    Timmer-Bonte, Johanna N. H.
    van der Drift, Miep A.
    van Leeuwen, Frank
    Wagenaar, Michiel
    van Die, Lya
    Bussink, Jan
    Tjan-Heijnen, Vivianne C. G.
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (06) : 988 - 996
  • [39] Phase II Study of Modified Carboplatin Plus Weekly Nab-Paclitaxel in Elderly Patients with Non-Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301
    Miyauchi, Eisaku
    Inoue, Akira
    Usui, Kazuhiro
    Sugawara, Shunichi
    Maemondo, Makoto
    Saito, Heisuke
    Fujita, Yuka
    Kato, Terufumi
    Suzuki, Toshiro
    Harada, Toshiyuki
    Watanabe, Hiroshi
    Nakagawa, Taku
    Ichinose, Masakazu
    ONCOLOGIST, 2017, 22 (06): : 640 - +
  • [40] Dose and schedule modifications of carboplatin plus nab-paclitaxel for elderly patients with squamous non-small cell lung cancer from the CAPITAL study
    Saito, G.
    Kogure, Y.
    Kada, A.
    Hashimoto, H.
    Atagi, S.
    Takiguchi, Y.
    Saka, H.
    Ebi, N.
    Inoue, A.
    Kurata, T.
    Yamanaka, T.
    Ando, M.
    Shibayama, T.
    Itani, H.
    Nishii, Y.
    Fujita, Y.
    Yamamoto, N.
    Gemma, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S1020 - S1021
12345